Alex Thompson

Stock Analyst at Stifel

(0)
# 4950
Out of 5,386 analysts
45
Total ratings
Success rate
Average return
22 Stocks
Name Action PT Current % Upside Ratings Updated
CGEM Cullinan Therapeutic...
Reinstates: Buy
22
7.76 183.51% 1 Jun 11, 2025
KYMR Kymera Therapeutics
Reinstates: Buy
55
44.15 24.58% 1 May 20, 2025
TVTX Travere Therapeutics
Maintains: Hold
22 23
14.76 55.83% 3 May 2, 2025
THRD Third Harmonic Bio
Downgrades: Hold
23 5
5.43 -7.92% 2 Mar 28, 2025
AVTX Avalo Therapeutics
Initiates Coverage On: Buy
36
4.71 664.33% 1 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
29.82 101.21% 1 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
200 207
171.99 20.36% 2 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
49
n/a n/a 1 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
30 57
n/a n/a 4 Jul 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
485 500
559.65 -10.66% 4 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
36 54
15.22 254.8% 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
44
17.65 149.29% 1 Feb 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
6 2
2.35 -14.89% 5 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
66 69
47.34 45.75% 2 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 1
1.45 -31.03% 4 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
40
14.34 178.94% 2 Sep 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
320
8.41 3704.99% 1 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
n/a n/a 1 Jul 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
28 34
16.12 110.92% 2 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
43 41
n/a n/a 3 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
33
1.26 2519.05% 1 Dec 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
37
n/a n/a 1 Sep 7, 2022